Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver T Keppler

Showing results (21-30 of 146) with videos related to

Pageof 15
Sort By:
Medical Microbiology and Immunology|May 22, 2026
Simultaneous quantification of anti-Spike IgG subclasses against various SARS-CoV-2 variants using a multiplex serological assayMarie L Bischof, Pascal Irrgang, Matthias Tenbusch, et al.
Journal of Virology|November 18, 2011
The cellular antiviral restriction factor tetherin does not inhibit poxviral replicationKatja Sliva, Theresa Resch, Benjamin Kraus, et al.
Retrovirology|January 17, 2009
Determinants in HIV-1 Nef for enhancement of virus replication and depletion of CD4+ T lymphocytes in human lymphoid tissue ex vivoStefanie Homann, Nadine Tibroni, Ingo Baumann, et al.
Molecular Biology of the Cell|June 16, 2006
The Nef protein of human immunodeficiency virus is a broad-spectrum modulator of chemokine receptor cell surface levels that acts independently of classical motifs for receptor endocytosis and Galphai signalingNico Michel, Kerstin Ganter, Stephanie Venzke, et al.
Cell Reports Methods|January 11, 2024
Activation-neutral gene editing of tonsillar CD4 T cells for functional studies in human ex vivo tonsil culturesKatharina Morath, Lopamudra Sadhu, Gerhard Dyckhoff, et al.
Journal of Virology|April 30, 2003
In vivo evolution of human immunodeficiency virus type 1 toward increased pathogenicity through CXCR4-mediated killing of uninfected CD4 T cellsAndreas Jekle, Oliver T Keppler, Erik De Clercq, et al.
Vaccine|May 6, 2014
Differential loss of humoral immunity against measles, mumps, rubella and varicella-zoster virus in children treated for cancerKonrad Bochennek, Regina Allwinn, Rebecca Langer, et al.
Immunogenetics|March 17, 2016
Evolutionary study of leporid CD4 reveals a hotspot of genetic variability within the D2 domainPatricia de Sousa-Pereira, Joana Abrantes, Hanna-Mari Baldauf, et al.
Journal of Virology|January 15, 2005
Rodent cells support key functions of the human immunodeficiency virus type 1 pathogenicity factor NefOliver T Keppler, Ina Allespach, Lismarie Schüller, et al.
Chemical Biology & Drug Design|June 2, 2012
Conformation-specific display of 4E10 and 2F5 epitopes on self-assembling protein nanoparticles as a potential HIV vaccineNewton Wahome, Tanya Pfeiffer, Ina Ambiel, et al.
Pageof 15

Showing results (21-30 of 146) with videos related to

Sort By:
Pageof 15
Medical Microbiology and Immunology|May 22, 2026
Simultaneous quantification of anti-Spike IgG subclasses against various SARS-CoV-2 variants using a multiplex serological assayMarie L Bischof, Pascal Irrgang, Matthias Tenbusch, et al.
Journal of Virology|November 18, 2011
The cellular antiviral restriction factor tetherin does not inhibit poxviral replicationKatja Sliva, Theresa Resch, Benjamin Kraus, et al.
Retrovirology|January 17, 2009
Determinants in HIV-1 Nef for enhancement of virus replication and depletion of CD4+ T lymphocytes in human lymphoid tissue ex vivoStefanie Homann, Nadine Tibroni, Ingo Baumann, et al.
Molecular Biology of the Cell|June 16, 2006
The Nef protein of human immunodeficiency virus is a broad-spectrum modulator of chemokine receptor cell surface levels that acts independently of classical motifs for receptor endocytosis and Galphai signalingNico Michel, Kerstin Ganter, Stephanie Venzke, et al.
Cell Reports Methods|January 11, 2024
Activation-neutral gene editing of tonsillar CD4 T cells for functional studies in human ex vivo tonsil culturesKatharina Morath, Lopamudra Sadhu, Gerhard Dyckhoff, et al.
Journal of Virology|April 30, 2003
In vivo evolution of human immunodeficiency virus type 1 toward increased pathogenicity through CXCR4-mediated killing of uninfected CD4 T cellsAndreas Jekle, Oliver T Keppler, Erik De Clercq, et al.
Vaccine|May 6, 2014
Differential loss of humoral immunity against measles, mumps, rubella and varicella-zoster virus in children treated for cancerKonrad Bochennek, Regina Allwinn, Rebecca Langer, et al.
Immunogenetics|March 17, 2016
Evolutionary study of leporid CD4 reveals a hotspot of genetic variability within the D2 domainPatricia de Sousa-Pereira, Joana Abrantes, Hanna-Mari Baldauf, et al.
Journal of Virology|January 15, 2005
Rodent cells support key functions of the human immunodeficiency virus type 1 pathogenicity factor NefOliver T Keppler, Ina Allespach, Lismarie Schüller, et al.
Chemical Biology & Drug Design|June 2, 2012
Conformation-specific display of 4E10 and 2F5 epitopes on self-assembling protein nanoparticles as a potential HIV vaccineNewton Wahome, Tanya Pfeiffer, Ina Ambiel, et al.
Pageof 15